Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens

Immunity

Volumn 22, Issue 5, 2005, Pages 571-581

  Zhou, Delu ^a,b   Li, Ping ^a,b   Lin, Yinling ^a,b   Lott, Jeremy M ^c   Hislop, Andrew D ^d   Canaday, David H ^e   Brutkiewicz, Randy R ^a,b   Blum, Janice S ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c Jackson State University   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; ELECTROPORATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ANTIGEN PRESENTATION; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CYTOPLASM; ELECTROPORATION; ENDOSOMES; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HSC70 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; LYSOSOMES; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 19344373577     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2005.03.009     Document Type: Article

References (43)

1. A.L. Ackerman, and P. Cresswell Cellular mechanisms governing cross-presentation of exogenous antigens Nat. Immunol. 5 2004 678 684
2. F.A. Agarraberes, S.R. Terlecky, and J.F. Dice An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation J. Cell Biol. 137 1997 825 834
3. K. Ahn, A. Gruhler, B. Galocha, T.R. Jones, E.J. Wiertz, H.L. Ploegh, P.A. Peterson, Y. Yang, and K. Fruh The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP Immunity 6 1997 613 621
4. M.J. Androlewicz, and P. Cresswell Human transporters associated with antigen processing possess a promiscuous peptide-binding site Immunity 1 1994 7 14
5. T.D. Armstrong, V.K. Clements, and S. Ostrand-Rosenberg MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes J. Immunol. 160 1998 661 666
6. B. Bercovich, I. Stancovski, A. Mayer, N. Blumenfeld, A. Laszlo, A.L. Schwartz, and A. Ciechanover Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70 J. Biol. Chem. 272 1997 9002 9010
7. D.H. Canaday, A. Gehring, E.G. Leonard, B. Eilertson, J.R. Schreiber, C.V. Harding, and W.H. Boom T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing J. Immunol. Methods 281 2003 129 142
8. H.L. Chiang, S.R. Terlecky, C.P. Plant, and J.F. Dice A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins Science 246 1989 382 385
9. R.M. Chicz, R.G. Urban, J.C. Gorga, D.A. Vignali, W.S. Lane, and J.L. Strominger Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles J. Exp. Med. 178 1993 27 47
10. A.M. Cuervo, and J.F. Dice A receptor for the selective uptake and degradation of proteins by lysosomes Science 273 1996 501 503
11. A.M. Cuervo, and J.F. Dice Unique properties of lamp2a compared to other lamp2 isoforms J. Cell Sci. 113 2000 4441 4450
12. J.M. den Haan, S.M. Lehar, and M.J. Bevan CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo J. Exp. Med. 192 2000 1685 1696
13. S.K. Dissanayake, N. Tuera, and S. Ostrand-Rosenberg Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome J. Immunol. 174 2005 1811 1819
14. J.L. Dul, D.P. Davis, E.K. Williamson, F.J. Stevens, and Y. Argon Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains J. Cell Biol. 152 2001 705 716
15. K. Fruh, K. Ahn, H. Djaballah, P. Sempe, P.M. van Endert, R. Tampe, P.A. Peterson, and Y. Yang A viral inhibitor of peptide transporters for antigen presentation Nature 375 1995 415 418
16. N.R. Gough, and D.M. Fambrough Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue J. Cell Biol. 137 1997 1161 1169
17. M.A. Haque, P. Li, S.K. Jackson, H.M. Zarour, J.W. Hawes, U.T. Phan, M. Maric, P. Cresswell, and J.S. Blum Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes J. Exp. Med. 195 2002 1267 1277
18. H. Hengel, J.O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G.J. Hammerling, U.H. Koszinowski, and F. Momburg A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter Immunity 6 1997 623 632
19. A. Hill, P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson Herpes simplex virus turns off the TAP to evade host immunity Nature 375 1995 411 415
20. S. Jacobson, R.P. Sekaly, C.L. Jacobson, H.F. McFarland, and E.O. Long HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells J. Virol. 63 1989 1756 1762
21. D. Jaraquemada, M. Marti, and E.O. Long An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells J. Exp. Med. 172 1990 947 954
22. D.S. Konecki, K. Foetisch, K.P. Zimmer, M. Schlotter, and U. Lichter-Konecki An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner Biochem. Biophys. Res. Commun. 215 1995 757 767
23. G. Lautscham, S. Mayrhofer, G. Taylor, T. Haigh, A. Leese, A. Rickinson, and N. Blake Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway J. Exp. Med. 194 2001 1053 1068
24. P.J. Lehner, J.T. Karttunen, G.W. Wilkinson, and P. Cresswell The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation Proc. Natl. Acad. Sci. USA 94 1997 6904 6909
25. J.D. Lich, J.F. Elliott, and J.S. Blum Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins J. Exp. Med. 191 2000 1513 1524
26. M.S. Malnati, M. Marti, T. LaVaute, D. Jaraquemada, W. Biddison, R. DeMars, and E.O. Long Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells Nature 357 1992 702 704
27. M.S. Malnati, S. Ceman, M. Weston, R. DeMars, and E.O. Long Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC J. Immunol. 151 1993 6751 6756
28. M.A. Maric, M.D. Taylor, and J.S. Blum Endosomal aspartic proteinases are required for invariant-chain processing Proc. Natl. Acad. Sci. USA 91 1994 2171 2175
29. D.B. Munafo, and M.I. Colombo A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation J. Cell Sci. 114 2001 3619 3629
30. S.L. Newmyer, and S.L. Schmid Dominant-interfering Hsc70 mutants disrupt multiple stages of the clathrin-coated vesicle cycle in vivo J. Cell Biol. 152 2001 607 620
31. F. Nimmerjahn, S. Milosevic, U. Behrends, E.M. Jaffee, D.M. Pardoll, G.W. Bornkamm, and J. Mautner Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy Eur. J. Immunol. 33 2003 1250 1259
32. I. Nishino, J. Fu, K. Tanji, T. Yamada, S. Shimojo, T. Koori, M. Mora, J.E. Riggs, S.J. Oh, and Y. Koga Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) Nature 406 2000 906 910
33. D.W. Ohannesian, D. Lotan, and R. Lotan Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate Cancer Res. 54 1994 5992 6000
34. C. Paludan, D. Schmid, M. Landthaler, M. Vockerodt, D. Kube, T. Tuschl, and C. Munz Endogenous MHC class II processing of a viral nuclear antigen after autophagy Science 307 2005 593 596
35. N. Panjwani, O. Akbari, S. Garcia, M. Brazil, and B. Stockinger The HSC73 molecular chaperone: involvement in MHC class II antigen presentation J. Immunol. 163 1999 1936 1942
36. S.S. Pathak, J.D. Lich, and J.S. Blum Cutting edge: editing of recycling class II:peptide complexes by HLA-DM J. Immunol. 167 2001 632 635
37. A. Rudensky, P. Preston-Hurlburt, S.C. Hong, A. Barlow, and C.A. Janeway Jr. Sequence analysis of peptides bound to MHC class II molecules Nature 353 1991 622 627
38. O. Saitoh, W.C. Wang, R. Lotan, and M. Fukuda Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials J. Biol. Chem. 267 1992 5700 5711
39. P.O. Seglen, and P.B. Gordon 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes Proc. Natl. Acad. Sci. USA 79 1982 1889 1892
40. K. Terada, K. Ohtsuka, N. Imamoto, Y. Yoneda, and M. Mori Role of heat shock cognate 70 protein in import of ornithine transcarbamylase precursor into mammalian mitochondria Mol. Cell. Biol. 15 1995 3708 3713
41. M.K. Tewari, G. Sinnathamby, D. Rajagopal, and L.C. Eisenlohr A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent Nat. Immunol. 6 2005 287 294
42. C.W. Wang, and D.J. Klionsky The molecular mechanism of autophagy Mol. Med. 9 2003 65 76
43. R.F. Wang, X. Wang, A.C. Atwood, S.L. Topalian, and S.A. Rosenberg Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen Science 284 1999 1351 1354